Early trial probes adding old drug to tough leukemia treatment for kids

This early study tested adding a daily oral drug called atovaquone to the standard, strong chemotherapy used for children and young adults newly diagnosed with acute myeloid leukemia (AML). The main goal was to see if patients could tolerate taking atovaquone alongside chemo without having to skip doses due to side effects like nausea. Researchers also closely measured the levels of atovaquone in the blood to understand how the body processes it during intensive treatment.